These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21255869)

  • 41. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
    Torok H; Taylor S; Baumann L; Jones T; Wieder J; Lowe N; Jarret M; Rich P; Pariser D; Tschen E; Martin D; Menter A; Weiss J
    J Drugs Dermatol; 2005; 4(5):592-7. PubMed ID: 16167418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
    Polder KD; Bruce S
    Dermatol Surg; 2012 Feb; 38(2):199-206. PubMed ID: 22093448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved quality of life with effective treatment of facial melasma: the pigment trial.
    Balkrishnan R; Kelly AP; McMichael A; Torok H
    J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
    Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melasma: treatment evaluation.
    Salem A; Gamil H; Ramadan A; Harras M; Amer A
    J Cosmet Laser Ther; 2009 Sep; 11(3):146-50. PubMed ID: 19340686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fractional nonablative 1540 nm laser resurfacing for thermal burn scars: a randomized controlled trial.
    Haedersdal M; Moreau KE; Beyer DM; Nymann P; Alsbjørn B
    Lasers Surg Med; 2009 Mar; 41(3):189-95. PubMed ID: 19291747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical metformin in the treatment of melasma: A preliminary clinical trial.
    Banavase Channakeshavaiah R; Andanooru Chandrappa NK
    J Cosmet Dermatol; 2020 May; 19(5):1161-1164. PubMed ID: 31502392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copper Bromide Laser vs Triple-Combination Cream for the Treatment of Melasma: A Randomized Clinical Trial.
    Hammami Ghorbel H; Boukari F; Fontas E; Montaudié H; Bahadoran P; Lacour JP; Passeron T
    JAMA Dermatol; 2015 Jul; 151(7):791-2. PubMed ID: 25715311
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
    Nanda S; Grover C; Reddy BS
    Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ablative fractional laser therapy as treatment for Becker nevus: a randomized controlled pilot study.
    Meesters AA; Wind BS; Kroon MW; Wolkerstorfer A; van der Veen JP; Nieuweboer-Krobotová L; van der Wal AC; Bos JD; Beek JF
    J Am Acad Dermatol; 2011 Dec; 65(6):1173-9. PubMed ID: 21641077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up.
    Niwa Massaki AB; Eimpunth S; Fabi SG; Guiha I; Groff W; Fitzpatrick R
    Lasers Surg Med; 2013 Feb; 45(2):95-101. PubMed ID: 23255085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
    Torok HM
    Am J Clin Dermatol; 2006; 7(4):223-30. PubMed ID: 16901182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study.
    Trelles MA; Velez M; Gold MH
    J Drugs Dermatol; 2010 Apr; 9(4):315-22. PubMed ID: 20514787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
    Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
    Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.